Streetwise Healthcare Services Sponsors
Select a name to see a detailed description, expert analysis and contact information.
|"The ovarian cancer trial of IMV's DPX-Survivac is nearing completion."|
|"We are initiating coverage on AUAU with a Buy rating; we consider the company's shares to be an attractive investment for exploration success."|
|"Recent samples remind us that LIO's Tuvatu still has a lot of upside."|
|"At 2017E, MAG had $160M in cash and a debt-free balance sheet."|
|"We'll keep EFR for the long term."|